The current study shows that the Epstein–Barr virus can interfere with the normal control of B cells. One viral protein ...

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

The immune system’s reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...

A University of Zurich–led study shows that multiple sclerosis arises from a molecular interaction between Epstein-Barr virus ...

Our results provide mechanistic evidence that immune responses to EBV can directly damage the brain in MS,” said Olivia Thomas, PhD, assistant professor at the Department of Clinical Neuroscience at ...

A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...

The FDA has issued a second complete response letter to Atara Biotherapeutics for its biologicals license application of ...

In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...

Atara Biotherapeutics received a second complete response letter from the FDA for its biologics license application for ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...